Ferritin in ferroptosis: Implications for neurodegenerative diseases (Review)

Billesbolle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, Schneider S, Arvedson T, Dror RO, Cheng Y and Manglik A: Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature. 586:807–811. 2020. View Article : Google Scholar : PubMed/NCBI

Lee J and Hyun DH: The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases. Antioxidants (Basel). 12:9182023. View Article : Google Scholar : PubMed/NCBI

Wei S, Qiu T, Yao X, Wang N, Jiang L, Jia X, Tao Y, Wang Z, Pei P, Zhang J, et al: Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway. J Hazard Mater. 384:1213902020. View Article : Google Scholar

Bossoni L, Labra-Munoz JA, van der Zant HSJ, Čaluković V, Lefering A, Egli R and Huber M: In-depth magnetometry and EPR analysis of the spin structure of human-liver ferritin: from DC to 9 GHz. Phys Chem Chem Phys. 25:27694–27717. 2023. View Article : Google Scholar : PubMed/NCBI

Arosio P, Elia L and Poli M: Ferritin, cellular iron storage and regulation. IUBMB Life. 69:414–422. 2017. View Article : Google Scholar : PubMed/NCBI

Jin X, Jiang C, Zou Z, Huang H, Li X, Xu S and Tan R: Ferritinophagy in the etiopathogenic mechanism of related diseases. J Nutr Biochem. 117:1093392023. View Article : Google Scholar : PubMed/NCBI

Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, et al: Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 5:e661–e671. 2020. View Article : Google Scholar : PubMed/NCBI

Oh ES: Dementia. Ann Intern Med. 177:ITC161–ITC176. 2024. View Article : Google Scholar : PubMed/NCBI

Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, et al: Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: Modelling study of Global Burden of disease study 2021. BMJ. 388:e0809522025. View Article : Google Scholar : PubMed/NCBI

Ashraf AA, Aljuhani M, Hubens CJ, Jeandriens J, Parkes HG, Geraki K, Mahmood A, Herlihy AH and So PW: Inflammation subsequent to mild iron excess differentially alters regional brain iron metabolism, oxidation and neuroinflammation status in mice. Front Aging Neurosci. 16:13933512024. View Article : Google Scholar : PubMed/NCBI

Shehjar F, James AW, Mahajan R and Shah ZA: Inhibition of iron-induced cofilin activation and inflammation in microglia by a novel cofilin inhibitor. J Neurochem. 169:e162602025. View Article : Google Scholar :

Tortuyaux R, Avila-Gutierrez K, Oudart M, Mazaré N, Mailly P, Deschemin JC, Vaulont S, Escartin C and Cohen-Salmon M: Physiopathological changes of ferritin mRNA density and distribution in hippocampal astrocytes in the mouse brain. J Neurochem. 164:847–857. 2023. View Article : Google Scholar

Mukherjee C, Kling T, Russo B, Miebach K, Kess E, Schifferer M, Pedro LD, Weikert U, Fard MK, Kannaiyan N, et al: Oligodendrocytes provide antioxidant defense function for neurons by secreting ferritin heavy chain. Cell Metab. 32:259–272 e10. 2020. View Article : Google Scholar : PubMed/NCBI

Baringer SL, Simpson IA and Connor JR: Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation. J Neurochem. 165:625–642. 2023. View Article : Google Scholar : PubMed/NCBI

Aisen P: Transferrin receptor 1. Int J Biochem Cell Biol. 36:2137–2143. 2004. View Article : Google Scholar : PubMed/NCBI

Yanatori I, Richardson DR, Toyokuni S and Kishi F: The new role of poly (rC)-binding proteins as iron transport chaperones: Proteins that could couple with inter-organelle interactions to safely traffic iron. Biochim Biophys Acta Gen Subj. 1864:1296852020. View Article : Google Scholar : PubMed/NCBI

Santos MCFD, Anderson CP, Neschen S, Zumbrennen-Bullough KB, Romney SJ, Kahle-Stephan M, Rathkolb B, Gailus-Durner V, Fuchs H, Wolf E, et al: Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification. Nat Commun. 11:2962020. View Article : Google Scholar : PubMed/NCBI

Chen L, Ma Y, Ma X, Liu L, Jv X, Li A, Shen Q, Jia W, Qu L, Shi L and Xie J: TFEB regulates cellular labile iron and prevents ferroptosis in a TfR1-dependent manner. Free Radic Biol Med. 208:445–457. 2023. View Article : Google Scholar : PubMed/NCBI

Lee WJ, Lee HG, Hur J, Lee GH, Won JP, Kim E, Hwang JS and Seo HG: PPARδ activation mitigates 6-OHDA-Induced neuronal damage by regulating intracellular iron levels. Antioxidants (Basel). 11:8102022. View Article : Google Scholar

Kang T, Han Z, Zhu L and Cao B: TFR1 knockdown alleviates iron overload and mitochondrial dysfunction during neural differentiation of Alzheimer's disease-derived induced pluripotent stem cells by interacting with GSK3B. Eur J Med Res. 29:1012024. View Article : Google Scholar : PubMed/NCBI

Zhai X, Yan W, Liu S, Tian L, Zhang Y, Zhao Y, Ni Y, Shen H, Wang J, Wan Z, et al: Silver nanoparticles induce iron accumulation-associated cognitive impairment via modulating neuronal ferroptosis. Environ Pollut. 346:1235552024. View Article : Google Scholar : PubMed/NCBI

Bengson EF, Guggisberg CA, Bastian TW, Georgieff MK and Ryu MS: Quantitative omics analyses of NCOA4 deficiency reveal an integral role of ferritinophagy in iron homeostasis of hippocampal neuronal HT22 cells. Front Nutr. 10:10548522023. View Article : Google Scholar : PubMed/NCBI

Fang Y, Chen X, Tan Q, Zhou H, Xu J and Gu Q: Inhibiting ferroptosis through disrupting the NCOA4-FTH1 Interaction: A new mechanism of action. ACS Cent Sci. 7:980–989. 2021. View Article : Google Scholar : PubMed/NCBI

Hoelzgen F, Nguyen TTP, Klukin E, Boumaiza M, Srivastava AK, Kim EY, Zalk R, Shahar A, Cohen-Schwartz S, Meyron-Holtz EG, et al: Structural basis for the intracellular regulation of ferritin degradation. Nat Commun. 15:38022024. View Article : Google Scholar : PubMed/NCBI

Miao SH, Sun HB, Ye Y, Yang JJ, Shi YW, Lu M, Hu G and Zhou JW: Astrocytic JWA expression is essential to dopaminergic neuron survival in the pathogenesis of Parkinson's disease. CNS Neurosci Ther. 20:754–762. 2014. View Article : Google Scholar : PubMed/NCBI

Zhao X, Kang Z, Han R, Wang M, Wang Y, Sun X, Wang C, Zhou J, Cao L and Lu M: JWA binding to NCOA4 alleviates degeneration in dopaminergic neurons through suppression of ferritinophagy in Parkinson's disease. Redox Biol. 73:1031902024. View Article : Google Scholar : PubMed/NCBI

Liu MR, Zhu WT and Pei DS: System Xc(-): A key regulatory target of ferroptosis in cancer. Invest New Drugs. 39:1123–1131. 2021. View Article : Google Scholar : PubMed/NCBI

Conrad M and Friedmann Angeli JP: Glutathione peroxidase 4 (Gpx4) and ferroptosis: What's so special about it? Mol Cell Oncol. 2:e9950472015. View Article : Google Scholar

Chen L, Li X, Liu L, Yu B, Xue Y and Liu Y: Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-ү-lyase function. Oncol Rep. 33:1465–1474. 2015. View Article : Google Scholar : PubMed/NCBI

Jiang X, Stockwell BR and Conrad M: Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI

Kuwata H and Hara S: Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism. Prostaglandins Other Lipid Mediat. 144:1063632019. View Article : Google Scholar : PubMed/NCBI

Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 13:81–90. 2017. View Article : Google Scholar :

Suzuki T, Motohashi H and Yamamoto M: Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci. 34:340–346. 2013. View Article : Google Scholar : PubMed/NCBI

Katoh Y, Itoh K, Yoshida E, Miyagishi M, Fukamizu A and Yamamoto M: Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells. 6:857–868. 2001. View Article : Google Scholar : PubMed/NCBI

Warnatz HJ, Schmidt D, Manke T, Piccini I, Sultan M, Borodina T, Balzereit D, Wruck W, Soldatov A, Vingron M, et al: The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J Biol Chem. 286:23521–23532. 2011. View Article : Google Scholar : PubMed/NCBI

An X, He J, Xie P, Li C, Xia M, Guo D, Bi B, Wu G, Xu J, Yu W and Ren Z: The effect of tau K677 lactylation on ferritinophagy and ferroptosis in Alzheimer's disease. Free Radic Biol Med. 224:685–706. 2024. View Article : Google Scholar : PubMed/NCBI

Zou K, Islam S, Sun Y, Gao Y, Nakamura T, Komano H, Tomita T and Michikawa M: Presenilin deficiency increases susceptibility to oxidative damage in fibroblasts. Front Aging Neurosci. 14:9025252022. View Article : Google Scholar : PubMed/NCBI

Pan R, Luo S, Huang Q, Li W, Cai T, Lai K and Shi X; Alzheimer's Disease Neuroimaging Initiative: The associations of cerebrospinal fluid ferritin with neurodegeneration and neuroinflammation along the Alzheimer's disease continuum. J Alzheimers Dis. 88:1115–1125. 2022. View Article : Google Scholar : PubMed/NCBI

Chaudhary S, Ashok A, McDonald D, Wise AS, Kritikos AE, Rana NA, Harding CV and Singh N: Upregulation of local hepcidin contributes to iron accumulation in Alzheimer's disease brains. J Alzheimers Dis. 82:1487–1497. 2021. View Article : Google Scholar : PubMed/NCBI

Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK and Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 113:1271–1276. 2004. View Article : Google Scholar : PubMed/NCBI

Raha AA, Biswas A, Henderson J, Chakraborty S, Holland A, Friedland RP, Mukaetova-Ladinska E, Zaman S and Raha-Chowdhury R: Interplay of ferritin accumulation and ferroportin loss in ageing brain: Implication for protein aggregation in down syndrome dementia, Alzheimer's, and Parkinson's diseases. Int J Mol Sci. 23:10602022. View Article : Google Scholar : PubMed/NCBI

Mayr E, Rotter J, Kuhrt H, Winter K, Stassart RM, Streit WJ and Bechmann I: Detection of molecular markers of ferroptosis in human Alzheimer's disease brains. J Alzheimers Dis. 102:1133–1154. 2024. View Article : Google Scholar : PubMed/NCBI

Streit WJ, Rotter J, Winter K, Muller W, Khoshbouei H and Bechmann I: Droplet degeneration of hippocampal and cortical neurons signifies the beginning of neuritic plaque formation. J Alzheimers Dis. 85:1701–1720. 2022. View Article : Google Scholar

Kenkhuis B, Somarakis A, de Haan L, Dzyubachyk O, Ijsselsteijn ME, de Miranda NFCC, Lelieveldt BPF, Dijkstra J, van Roon-Mom WMC, Höllt T and van der Weerd L: Iron loading is a prominent feature of activated microglia in Alzheimer's disease patients. Acta Neuropathol Commun. 9:272021. View Article : Google Scholar : PubMed/NCBI

Munoz-Castro C, Noori A, Magdamo CG, Li Z, Marks JD, Frosch MP, Das S, Hyman BT and Serrano-Pozo A: Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer's disease. J Neuroinflammation. 19:302022. View Article : Google Scholar : PubMed/NCBI

Kenkhuis B, van Eekeren M, Parfitt DA, Ariyurek Y, Banerjee P, Priller J, van der Weerd L and van Roon-Mom WMC: Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia. Stem Cell Reports. 17:1351–1365. 2022. View Article : Google Scholar : PubMed/NCBI

Black E, Rasch A, Wimmer T, Li A, Araujo A, Cieslak S, Steed KS, Adhikari RD, Wisco JJ and Hutchinson BA: The effects of age, genotype and diet on hippocampal subfield iron dysregulation and Alzheimer's disease biomarkers in an ApoE mouse model. Eur J Neurosci. 57:1033–1047. 2023. View Article : Google Scholar : PubMed/NCBI

Belaidi AA, Masaldan S, Southon A, Kalinowski P, Acevedo K, Appukuttan AT, Portbury S, Lei P, Agarwal P, Leurgans SE, et al: Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy. Mol Psychiatry. 29:211–220. 2024. View Article : Google Scholar

Ayton S, Janelidze S, Kalinowski P, Palmqvist S, Belaidi AA, Stomrud E, Roberts A, Roberts B, Hansson O and Bush AI: CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers. J Neurol Neurosurg Psychiatry. 94:211–219. 2023. View Article : Google Scholar

Shen QQ, Jv XH, Ma XZ, Li C, Liu L, Jia WT, Qu L, Chen LL and Xie JX: Cell senescence induced by toxic interaction between alpha-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease. Acta Pharmacol Sin. 45:268–281. 2024. View Article : Google Scholar

Li X, Si W, Li Z, Tian Y, Liu X, Ye S, Huang Z, Ji Y, Zhao C, Hao X, et al: miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson's disease. Int J Mol Med. 47:612021. View Article : Google Scholar

Lv QK, Tao KX, Yao XY, Pang MZ, Cao BE, Liu CF and Wang F: Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho-1/Gpx4 pathway to prevent α-synuclein-induced ferroptosis in Parkinson's disease. J Pineal Res. 76:e129482024. View Article : Google Scholar

Martin-Bastida A, Tilley BS, Bansal S, Gentleman SM, Dexter DT and Ward RJ: Iron and inflammation: In vivo and post-mortem studies in Parkinson's disease. J Neural Transm (Vienna). 128:15–25. 2021. View Article : Google Scholar

Khan SS, Jaimon E, Lin YE, Nikoloff J, Tonelli F, Alessi DR and Pfeffer SR: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson's disease. Proc Natl Acad Sci USA. 121:e24022061212024. View Article : Google Scholar : PubMed/NCBI

Mamais A, Kluss JH, Bonet-Ponce L, Landeck N, Langston RG, Smith N, Beilina A, Kaganovich A, Ghosh MC, Pellegrini L, et al: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia. PLoS Biol. 19:e30014802021. View Article : Google Scholar : PubMed/NCBI

Friedrich I, Reimann K, Jankuhn S, Kirilina E, Stieler J, Sonntag M, Meijer J, Weiskopf N, Reinert T, Arendt T and Morawski M: Cell specific quantitative iron mapping on brain slices by immuno-μPIXE in healthy elderly and Parkinson's disease. Acta Neuropathol Commun. 9:472021. View Article : Google Scholar

Hu Y, Guo P, Lian TH, Zuo LJ, Yu SY, Liu L, Jin Z, Yu QJ, Wang RD, Li LX, et al: Clinical characteristics, iron metabolism and neuroinflammation: New insight into excessive daytime sleepiness in Parkinson's disease. Neuropsychiatr Dis Treat. 17:2041–2051. 2021. View Article : Google Scholar : PubMed/NCBI

Maggi G, Barone A, Mastromarino C, Santangelo G and Vitale C: Prevalence and clinical profile of patients with restless legs syndrome in Parkinson's disease: A meta-analysis. Sleep Med. 121:275–286. 2024. View Article : Google Scholar : PubMed/NCBI

Swanson MEV, Mrkela M, Murray HC, Cao MC, Turner C, Curtis MA, Faull RLM, Walker AK and Scotter EL: Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain. Acta Neuropathol Commun. 11:692023. View Article : Google Scholar : PubMed/NCBI

Gao J, Okolo O, Siedlak SL, Friedland RP and Wang X: Ferritin is closely associated with microglia in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 83:917–926. 2024. View Article : Google Scholar : PubMed/NCBI

Halon-Golabek M, Flis DJ, Zischka H, Akdogan B, Wieckowski MR, Antosiewicz J and Ziolkowski W: Amyotrophic lateral sclerosis associated disturbance of iron metabolism is blunted by swim training-role of AKT signaling pathway. Biochim Biophys Acta Mol Basis Dis. 1870:1670142024. View Article : Google Scholar : PubMed/NCBI

Wang JC, Ramaswami G and Geschwind DH: Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility. Sci Rep. 11:57482021. View Article : Google Scholar : PubMed/NCBI

Caplan DN, Rapalino O, Karaa A, Rosovsky RP and Uljon S: Case 35-2020: A 59-year-old woman with type 1 diabetes mellitus and obtundation. N Engl J Med. 383:1974–1983. 2020. View Article : Google Scholar : PubMed/NCBI

Niu L, Zhou Y, Lu L, Su A and Guo X: Ceruloplasmin deficiency impaired brain iron metabolism and behavior in mice. Cell Biochem Biophys. 80:385–393. 2022. View Article : Google Scholar : PubMed/NCBI

Vroegindeweij LHP, Bossoni L, Boon AJW, Wilson JHP, Bulk M, Labra-Muñoz J, Huber M, Webb A, van der Weerd L and Langendonk JG: Quantification of different iron forms in the aceruloplasminemia brain to explore iron-related neurodegeneration. Neuroimage Clin. 30:1026572021. View Article : Google Scholar : PubMed/NCBI

Lobbes H, Reynaud Q, Mainbourg S, Savy-Stortz C, Ropert M, Bardou-Jacquet E and Durupt S: A new pathogenic missense variant in a consanguineous north-african family responsible for a highly variable aceruloplasminemia phenotype: A case-report. Front Neurosci. 16:9063602022. View Article : Google Scholar : PubMed/NCBI

Sanz-Alcazar A, Portillo-Carrasquer M, Delaspre F, Pazos-Gil M, Tamarit J, Ros J and Cabiscol E: Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3β in the impairment of the NRF2 response. Redox Biol. 76:1033392024. View Article : Google Scholar

Koeppen AH: Tissue iron in friedreich ataxia. J Integr Neurosci. 23:42024. View Article : Google Scholar : PubMed/NCBI

Grander M, Haschka D, Indelicato E, Kremser C, Amprosi M, Nachbauer W, Henninger B, Stefani A, Högl B, Fischer C, et al: Genetic determined iron starvation signature in friedreich's ataxia. Mov Disord. 39:1088–1098. 2024. View Article : Google Scholar : PubMed/NCBI

Kurzawa-Akanbi M, Keogh M, Tsefou E, Ramsay L, Johnson M, Keers S, Wsa Ochieng L, McNair A, Singh P, Khan A, et al: Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress. Neuropathol Appl Neurobiol. 47:26–42. 2021. View Article : Google Scholar

Shahidehpour RK, Nelson PT and Bachstetter AD: A pathologic study of Perivascular pTDP-43 Lin bodies in LATE-NC. Acta Neuropathol Commun. 12:1142024. View Article : Google Scholar : PubMed/NCBI

Abu Bakar ZH, Bellier JP, Yanagisawa D, Kato T, Mukaisho KI and Tooyama I: LC3/FtMt colocalization patterns reveal the progression of FtMt accumulation in nigral neurons of patients with progressive supranuclear palsy. Int J Mol Sci. 23:5372022. View Article : Google Scholar : PubMed/NCBI

Li X, Chu Y, Ma R, Dou M, Li S, Song Y, Lv Y and Zhu L: Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis. J Neuroimmunol. 373:5779952022. View Article : Google Scholar : PubMed/NCBI

Shukla JJ, Stefanova N, Bush AI, McColl G, Finkelstein DI and McAllum EJ: Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy. Neurobiol Dis. 159:1055092021. View Article : Google Scholar : PubMed/NCBI

Gromadzka G, Wierzbicka D, Litwin T and Przybylkowski A: Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease. Biometals. 34:407–414. 2021. View Article : Google Scholar : PubMed/NCBI

Xie Z, Wang X, Luo X, Yan J, Zhang J, Sun R, Luo A and Li S: Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis. Biochem Pharmacol. 207:1153742023. View Article : Google Scholar

Zimmer TS, David B, Broekaart DWM, Schidlowski M, Ruffolo G, Korotkov A, van der Wel NN, van Rijen PC, Mühlebner A, van Hecke W, et al: Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy. Acta Neuropathol. 142:729–759. 2021. View Article : Google Scholar : PubMed/NCBI

Brosseron F, Maass A, Kleineidam L, Ravichandran KA, González PG, McManus RM, Ising C, Santarelli F, Kolbe CC, Häsler LM, et al: Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease. Neuron. 110:1009–1022 e4. 2022. View Article : Google Scholar : PubMed/NCBI

Ayton S, Janelidze S, Roberts B, Palmqvist S, Kalinowski P, Diouf I, Belaidi AA, Stomrud E, Bush AI and Hansson O: Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE epsilon4, sex and age. Prog Neurobiol. 198:1019042021. View Article : Google Scholar

Gong L, Sun J and Cong S: Levels of iron and iron-related proteins in Alzheimer's disease: A systematic review and meta-analysis. J Trace Elem Med Biol. 80:1273042023. View Article : Google Scholar : PubMed/NCBI

Brosseron F, Kleemann K, Kolbe CC, Santarelli F, Castro-Gomez S, Tacik P, Latz E, Jessen F and Heneka MT: Interrelations of Alzheimer s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation. J Neurochem. 157:2210–2224. 2021. View Article : Google Scholar

Banerjee G, Forsgard N, Ambler G, Keshavan A, Paterson RW, Foiani MS, Toombs J, Heslegrave A, Thompson EJ, Lunn MP, et al: Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: An exploratory analysis. J Neurol. 269:1470–1475. 2022. View Article : Google Scholar :

Li Y, Duan L, Shi Y, Qi J and Li T: Diagnostic accuracy of combined measurement of serum homocysteine, C-Reactive protein, and serum ferritin in mild cognitive impairments and Alzheimer's disease. J Coll Physicians Surg Pak. 34:1303–1308. 2024. View Article : Google Scholar : PubMed/NCBI

Baldini A, Greco A, Lomi M, Giannelli R, Canale P, Diana A, Dolciotti C, Del Carratore R and Bongioanni P: Blood analytes as biomarkers of mechanisms involved in Alzheimer's disease progression. Int J Mol Sci. 23:132892022. View Article : Google Scholar : PubMed/NCBI

Traub J, Otto M, Sell R, Göpfert D, Homola G, Steinacker P, Oeckl P, Morbach C, Frantz S, Pham M, et al: Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients. Alzheimers Res Ther. 14:1492022. View Article : Google Scholar : PubMed/NCBI

Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E and Agundez JAG: Biological fluid levels of iron and iron-related proteins in Parkinson's disease: Review and meta-analysis. Eur J Neurol. 28:1041–1055. 2021. View Article : Google Scholar

Maass F, Michalke B, Willkommen D, Canaslan S, Schmitz M, Bähr M, Zerr I and Lingor P: Cerebrospinal fluid iron-ferritin ratio as a potential progression marker for Parkinson's disease. Mov Disord. 36:2967–2969. 2021. View Article : Google Scholar : PubMed/NCBI

Melek IM, Kus B, Kaptan Z and Petekkaya E: Correlation of metal ions with specific brain region volumes in neurodegenerative diseases. Turk J Med Sci. 53:1465–1475. 2023. View Article : Google Scholar

Ayton S, Hall S, Janelidze S, Kalinowski P, Palmqvist S, Belaidi AA, Roberts B, Roberts A, Stomrud E, Bush AI and Hansson O: The neuroinflammatory acute phase response in parkinsonian-related disorders. Mov Disord. 37:993–1003. 2022. View Article : Google Scholar : PubMed/NCBI

Tripathi CB, Gangania M, Kushwaha S and Agarwal R: Evidence-Based discriminant analysis: A new insight into iron profile for the diagnosis of Parkinson's disease. Ann Indian Acad Neurol. 24:234–238. 2021. View Article : Google Scholar : PubMed/NCBI

Barmaki H, Morovati A, Eydivandi Z, Jafari Naleshkenani F, Saedi S, Musavi H, Abbasi M and Hemmati-Dinarvand M: The Association between Serum Oxidative Stress Indexes and Pathogenesis of Parkinson's disease in the northwest of iran. Iran J Public Health. 50:606–615. 2021.PubMed/NCBI

Xu Y, Huang X, Geng X and Wang F: Meta-analysis of iron metabolism markers levels of Parkinson's disease patients determined by fluid and MRI measurements. J Trace Elem Med Biol. 78:1271902023. View Article : Google Scholar : PubMed/NCBI

Galper J, Balwani M, Fahn S, Waters C, Krohn L, Gan-Or Z, Dzamko N and Alcalay RN: Cytokines and gaucher biomarkers in glucocerebrosidase carriers with and without parkinson disease. Mov Disord. 36:1451–1455. 2021. View Article : Google Scholar : PubMed/NCBI

Spence H, Mengoa-Fleming S, Sneddon AA, McNeil CJ and Waiter GD: Associations between sex, systemic iron and inflammatory status and subcortical brain iron. Eur J Neurosci. 60:5069–5085. 2024. View Article : Google Scholar : PubMed/NCBI

Chen H, Wang X, Chang Z, Zhang J and Xie D: Evidence for genetic causality between iron homeostasis and Parkinson's disease: A two-sample Mendelian randomization study. J Trace Elem Med Biol. 84:1274302024. View Article : Google Scholar : PubMed/NCBI

Thompson AG, Gray E, Verber N, Bobeva Y, Lombardi V, Shepheard SR, Yildiz O, Feneberg E, Farrimond L, Dharmadasa T, et al: Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain. Brain Commun. 4:fcac0292022. View Article : Google Scholar : PubMed/NCBI

Cheng Y, Chen Y and Shang H: Aberrations of biochemical indicators in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Transl Neurodegener. 10:32021. View Article : Google Scholar : PubMed/NCBI

Song C, Chu Z, Dai J, Xie D, Qin T, Xie L, Zhai Z, Huang S, Xu Y and Sun T: Water extract of moschus alleviates erastin-induced ferroptosis by regulating the Keap1/Nrf2 pathway in HT22 cells. J Ethnopharmacol. 326:1179372024. View Article : Google Scholar

Zhang H, Liu QQ, Ding SK, Li H and Shang YZ: Flavonoids from stems and leaves of scutellaria baicalensis georgi improve composited Aβ-Induced Alzheimer's disease model rats' memory and neuroplasticity disorders. Comb Chem High Throughput Screen. 26:1519–1532. 2023. View Article : Google Scholar

Shamsi A, Shahwan M, Khan MS, Husain FM, Alhumaydhi FA, Aljohani ASM, Rehman MT, Hassan MI and Islam A: Elucidating the interaction of human ferritin with quercetin and naringenin: Implication of natural products in neurodegenerative diseases: molecular docking and dynamics simulation insight. ACS Omega. 6:7922–7930. 2021. View Article : Google Scholar : PubMed/NCBI

Shahwan M, Alhumaydhi FA, Sharaf SE, Alghamdi BS, Baeesa S, Tayeb HO, Ashraf GM and Shamsi A: Computational insight into the binding of bryostatin 1 with ferritin: Implication of natural compounds in Alzheimer's disease therapeutics. J Biomol Struct Dyn. 41:5635–5645. 2023. View Article : Google Scholar

Mukem S, Sayoh I, Maungchanburi S and Thongbuakaew T: Ebselen, iron uptake inhibitor, alleviates iron overload-induced senescence-like neuronal cells SH-SY5Y via suppressing the mTORC1 signaling pathway. Adv Pharmacol Pharm Sci. 2023:66413472023.PubMed/NCBI

Shahwan M, Khan MS, Husain FM and Shamsi A: Understanding binding between donepezil and human ferritin: molecular docking and molecular dynamics simulation approach. J Biomol Struct Dyn. 40:3871–3879. 2022. View Article : Google Scholar

Xia Y, Wang H, Xie Z, Liu ZH and Wang HL: Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model. Free Radic Biol Med. 211:63–76. 2024. View Article : Google Scholar

Li M, Zhang J, Jiang L, Wang W, Feng X, Liu M and Yang D: Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson's disease via inhibiting oxidative stress and ferroptosis. BMC Complement Med Ther. 23:2182023. View Article : Google Scholar : PubMed/NCBI

Chen Y, Li YY, Wang S, Zhou T, Chen NH and Yuan YH: Ginsenoside Rg1 plays a neuroprotective role in regulating the iron-regulated proteins and against lipid peroxidation in oligodendrocytes. Neurochem Res. 47:1721–1735. 2022. View Article : Google Scholar : PubMed/NCBI

Zheng Q, Ma P, Yang P, Zhai S, He M, Zhang X, Tu Q, Jiao L, Ye L, Feng Z and Zhang C: Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease. Neurosci Lett. 810:1373462023. View Article : Google Scholar : PubMed/NCBI

Li QM, Wu SZ, Zha XQ, Zang DD, Zhang FY and Luo JP: Ganoderic acid A mitigates dopaminergic neuron ferroptosis via inhibiting NCOA4-mediated ferritinophagy in Parkinson's disease mice. J Ethnopharmacol. 332:1183632024. View Article : Google Scholar : PubMed/NCBI

Sun Q, Wang Y, Hou L, Li S, Hong JS, Wang Q and Zhao J: Clozapine-N-oxide protects dopaminergic neurons against rotenone-induced neurotoxicity by preventing ferritinophagy-mediated ferroptosis. Free Radic Biol Med. 212:384–402. 2024. View Article : Google Scholar : PubMed/NCBI

Scarpellini C, Klejborowska G, Lanthier C, Hassannia B, Vanden Berghe T and Augustyns K: Beyond ferrostatin-1: A comprehensive review of ferroptosis inhibitors. Trends Pharmacol Sci. 44:902–916. 2023. View Article : Google Scholar : PubMed/NCBI

Gu C, Zhang T, Lv C, Liu Y, Wang Y and Zhao G: His-mediated reversible self-assembly of ferritin nanocages through two different switches for encapsulation of cargo molecules. ACS Nano. 14:17080–17090. 2020. View Article : Google Scholar : PubMed/NCBI

Barolo L, Gigante Y, Mautone L, Ghirga S, Soloperto A, Giorgi A, Ghirga F, Pitea M, Incocciati A, Mura F, et al: Ferritin nanocage-enabled detection of pathological tau in living human retinal cells. Sci Rep. 14:115332024. View Article : Google Scholar : PubMed/NCBI

Morasso C, Truffi M, Tinelli V, Stivaktakis P, Di Gerlando R, Francesca D, Perini G, Faisal M, Aid J, Noridov B, et al: Exploring the anti-inflammatory effects of curcumin encapsulated within ferritin nanocages: A comprehensive in vivo and in vitro study in Alzheimer's disease. J Nanobiotechnology. 22:7182024. View Article : Google Scholar : PubMed/NCBI

Xia X, Li H, Xu X, Zhao G and Du M: Facilitating pro-survival mitophagy for alleviating Parkinson's disease via sequence-targeted lycopene nanodots. ACS Nano. 17:17979–17995. 2023. View Article : Google Scholar : PubMed/NCBI

Strbak O, Balejcikova L, Kmetova M, Gombos J, Kovac J, Dobrota D and Kopcansky P: Longitudinal and transverse relaxivity analysis of native ferritin and magnetoferritin at 7 T MRI. Int J Mol Sci. 22:84872021. View Article : Google Scholar : PubMed/NCBI

Filo S, Shaharabani R, Bar Hanin D, Adam M, Ben-David E, Schoffman H, Margalit N, Habib N, Shahar T and Mezer AA: Non-invasive assessment of normal and impaired iron homeostasis in the brain. Nat Commun. 14:54672023. View Article : Google Scholar : PubMed/NCBI

Bossoni L, Hegeman-Kleinn I, van Duinen SG, Bulk M, Vroegindeweij LHP, Langendonk JG, Hirschler L, Webb A and van der Weerd L: Off-resonance saturation as an MRI method to quantify mineral-iron in the post-mortem brain. Magn Reson Med. 87:1276–1288. 2022. View Article : Google Scholar :

Brammerloh M, Morawski M, Friedrich I, Reinert T, Lange C, Pelicon P, Vavpetič P, Jankuhn S, Jäger C, Alkemade A, et al: Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry. Neuroimage. 239:1182552021. View Article : Google Scholar : PubMed/NCBI

Luyken AK, Lappe C, Viard R, Löhle M, Kleinlein HR, Kuchcinski G, Langner S, Wenzel AM, Walter M, Weber MA, et al: High correlation of quantitative susceptibility mapping and echo intensity measurements of nigral iron overload in Parkinson's disease. J Neural Transm (Vienna). 132:407–417. 2025. View Article : Google Scholar :

Ying CC, Wang CS, Ren YK, Ding CW, Zhang YC, Wu J, Yang M, Zhang Y, Mao P, Sheng YJ, et al: Correlation between substantia nigra hyperechogenicity and iron metabolism in the postural instability gait difficulty subtype of Parkinson's disease. Ultrasound Med Biol. 49:2422–2427. 2023. View Article : Google Scholar : PubMed/NCBI

Hu Y, Wu L, Yang SQ, Wei HJ, Wang CY, Kang X, Jiang JM, Zhang P and Tang XQ: Formaldehyde induces ferritinophagy to damage hippocampal neuronal cells. Toxicol Ind Health. 37:685–694. 2021. View Article : Google Scholar : PubMed/NCBI

Tang YH, Wu L, Huang HL, Zhang PP, Zou W, Tang XQ and Tang YY: Hydrogen sulfide antagonizes formaldehyde-induced ferroptosis via preventing ferritinophagy by upregulation of GDF11 in HT22 cells. Toxicology. 491:1535172023. View Article : Google Scholar : PubMed/NCBI

Xiong Q, Tian X, Xu C, Ma B, Liu W, Sun B, Ru Q and Shu X: PM(2.5) exposure-induced ferroptosis in neuronal cells via inhibiting ERK/CREB pathway. Environ Toxicol. 37:2201–2213. 2022. View Article : Google Scholar : PubMed/NCBI

Guo CC, Xu ZM, Lyu Y, Li XH, Li ZF, He H, Tian FJ and Zheng JP: PM(2.5) induces autophagy-dependent ferroptosis by endoplasmic reticulum stress in SH-SY5Y cells. J Appl Toxicol. 43:1013–1025. 2023. View Article : Google Scholar : PubMed/NCBI

Liu ZH, Zhai Y, Xia Y and Liao Q: Mating modifies oxidative stress in the brain and confers protection against Parkinson's disease in a Drosophila model. Biochem Biophys Res Commun. 737:1509112024. View Article : Google Scholar : PubMed/NCBI

Pino JMV, Nishiduka ES, da Luz MHM, Silva VF, Antunes HKM, Tashima AK, Guedes PLR, de Souza AAL and Lee KS: Iron-deficient diet induces distinct protein profile related to energy metabolism in the striatum and hippocampus of adult rats. Nutr Neurosci. 25:207–218. 2022. View Article : Google Scholar

Chen M, Xu E, Zeng C, Zhu W, Zheng J and Chen H: High dietary iron has a greater impact on brain iron homeostasis and cognitive function in old compared with young C57BL/6J male mice. J Nutr. 151:2835–2842. 2021. View Article : Google Scholar : PubMed/NCBI

Susgun S, Demirel M, Yalcin Cakmakli G, Salman B, Oguz KK, Elibol B, Ugur Iseri SA and Yapici Z: Targeted resequencing reveals high-level mosaicism for a novel frameshift variant in WDR45 associated with beta-propeller protein-associated neurodegeneration. Int J Neurosci. 134:1040–1045. 2024. View Article : Google Scholar

Aring L, Choi EK, Kopera H, Lanigan T, Iwase S, Klionsky DJ and Seo YA: A neurodegeneration gene, WDR45, links impaired ferritinophagy to iron accumulation. J Neurochem. 160:356–375. 2022. View Article : Google Scholar :

Tsukida K, Muramatsu SI, Osaka H, Yamagata T and Muramatsu K: WDR45 variants cause ferrous iron loss due to impaired ferritinophagy associated with nuclear receptor coactivator 4 and WD repeat domain phosphoinositide interacting protein 4 reduction. Brain Commun. 4:fcac3042022. View Article : Google Scholar

Luo C, Wu G, Xiao Z, Hu R, Qiao M, Li W, Liu C, Li Z, Lan C and Huang Z: Role of miRNA regulation in IGFBP-2 overexpression and neuronal ferroptosis: Insights into the Nrf2/SLC7A11/GPX4 pathway in Alzheimer's disease. Int J Biol Macromol. 287:1385372025. View Article : Google Scholar

Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafò MR, Palmer T, Schooling CM, Wallace C, Zhao Q and Smith GD: Mendelian randomization. Nat Rev Methods Primers. 2:62022. View Article : Google Scholar : PubMed/NCBI

Fedak KM, Bernal A, Capshaw ZA and Gross S: Applying the bradford hill criteria in the 21st century: How data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 12:142015. View Article : Google Scholar : PubMed/NCBI

Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, Wu J, Tang H, Zheng S, Liu Y, et al: Generic diagramming platform (GDP): A comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 53:D1670–D1676. 2025. View Article : Google Scholar :